InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.94
(
-0.45%
)
Bitcoin
54,424.61
(
-4.48%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ECole

Send PM Follow Ignore
Followers 21
Posts 1331
Boards Moderated 1
Alias Born 07/02/2013

ECole

Re: None

Thursday, 08/08/2013 12:42:19 AM

Thursday, August 08, 2013 12:42:19 AM

Post# of 80490
Earnings call highlights

R&D expenses increased, now expect research and development expenses of $200 million to $208 million.
SG&A expenses increased by $29.9 million from the second quarter of 2012

http://www.earningsimpact.com/Transcript/82589/ARIA/Ariad-Pharmaceuticals%2c-Inc----Q2-2013-Earnings-Call
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up